As a novel therapeutic target, MIR31 has been extensively studied in various diseases such as colorectal cancer (Zhao et al., 2020), nasopharyngeal carcinoma (Wu et al., 2016). Here, MIR31 is linked to nasopharyngeal carcinoma.